Mather Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mather Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$120K	Buy	+936	New	+$117K	﹤0.01%	852
2025 Q4	–	Sell	-46	Closed	-$4.61K	–	1664
2025 Q3	$4.61K	Buy	+46	New	+$4.14K	﹤0.01%	1407
2025 Q2	–	Sell	-48	Closed	-$3.89K	–	1743
2025 Q1	$3.89K	Hold	48	–	–	﹤0.01%	1449
2024 Q4	$4.32K	Hold	48	–	–	﹤0.01%	1402
2024 Q3	$4.74K	Sell	48 -827	-95%	-$81.3K	﹤0.01%	1308
2024 Q2	$83K	Buy	875 +827	+1,723%	+$74.1K	﹤0.01%	859
2024 Q1	$4.29K	Buy	+48	New	+$4.45K	﹤0.01%	1378
2014 Q2	–	Sell	-193,710	Closed	-$9.2M	–	25
2014 Q1	$9.2M	Sell	193,710 -38,562	-17%	-$1.97M	3.37%	13
2013 Q4	$10.1M	Buy	232,272 +3,801	+2%	+$157K	3.84%	11
2013 Q3	$9.84M	Sell	228,471 -2,940	-1%	-$119K	4.08%	10
2013 Q2	$8.04M	Buy	+231,411	New	+$8.13M	3.47%	12

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Mather Group's XBI Position: Q1 2026 in Review

Mather Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 936 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #852 among its holdings. This is a return to the name: Mather Group previously reported a position in XBI as recently as Q3 2025.

Mather Group first reported a position in XBI in Q2 2013 and has held it in 11 quarters since. The position peaked at $10.1M in Q4 2013. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Mather Group held 936 shares of State Street SPDR S&P Biotech ETF worth $120K as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Mather Group position in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #852 holding.
Mather Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 11 quarters since.
Mather Group's State Street SPDR S&P Biotech ETF position peaked at $10.1M in Q4 2013.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.